2-169205568-G-C

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_004525.3(LRP2):​c.7626C>G​(p.Arg2542Arg) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0677 in 1,613,650 control chromosomes in the GnomAD database, including 6,434 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. R2542R) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.12 ( 2161 hom., cov: 32)
Exomes 𝑓: 0.062 ( 4273 hom. )

Consequence

LRP2
NM_004525.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 0.288

Publications

13 publications found
Variant links:
Genes affected
LRP2 (HGNC:6694): (LDL receptor related protein 2) The protein encoded by this gene, low density lipoprotein-related protein 2 (LRP2) or megalin, is a multi-ligand endocytic receptor that is expressed in many different tissues but primarily in absorptive epithilial tissues such as the kidney. This glycoprotein has a large amino-terminal extracellular domain, a single transmembrane domain, and a short carboxy-terminal cytoplasmic tail. The extracellular ligand-binding-domains bind diverse macromolecules including albumin, apolipoproteins B and E, and lipoprotein lipase. The LRP2 protein is critical for the reuptake of numerous ligands, including lipoproteins, sterols, vitamin-binding proteins, and hormones. This protein also has a role in cell-signaling; extracellular ligands include parathyroid horomones and the morphogen sonic hedgehog while cytosolic ligands include MAP kinase scaffold proteins and JNK interacting proteins. Recycling of this membrane receptor is regulated by phosphorylation of its cytoplasmic domain. Mutations in this gene cause Donnai-Barrow syndrome (DBS) and facio-oculoacoustico-renal syndrome (FOAR).[provided by RefSeq, Aug 2009]
LRP2 Gene-Disease associations (from GenCC):
  • Donnai-Barrow syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet
  • Stickler syndrome
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • intellectual disability
    Inheritance: AD Classification: LIMITED Submitted by: G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.73).
BP6
Variant 2-169205568-G-C is Benign according to our data. Variant chr2-169205568-G-C is described in ClinVar as Benign. ClinVar VariationId is 129536.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.288 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.303 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004525.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LRP2
NM_004525.3
MANE Select
c.7626C>Gp.Arg2542Arg
synonymous
Exon 41 of 79NP_004516.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LRP2
ENST00000649046.1
MANE Select
c.7626C>Gp.Arg2542Arg
synonymous
Exon 41 of 79ENSP00000496870.1

Frequencies

GnomAD3 genomes
AF:
0.124
AC:
18804
AN:
151834
Hom.:
2156
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.307
Gnomad AMI
AF:
0.0899
Gnomad AMR
AF:
0.0691
Gnomad ASJ
AF:
0.0248
Gnomad EAS
AF:
0.00424
Gnomad SAS
AF:
0.100
Gnomad FIN
AF:
0.0494
Gnomad MID
AF:
0.0443
Gnomad NFE
AF:
0.0538
Gnomad OTH
AF:
0.0954
GnomAD2 exomes
AF:
0.0688
AC:
17308
AN:
251426
AF XY:
0.0666
show subpopulations
Gnomad AFR exome
AF:
0.313
Gnomad AMR exome
AF:
0.0351
Gnomad ASJ exome
AF:
0.0271
Gnomad EAS exome
AF:
0.00392
Gnomad FIN exome
AF:
0.0475
Gnomad NFE exome
AF:
0.0541
Gnomad OTH exome
AF:
0.0618
GnomAD4 exome
AF:
0.0619
AC:
90493
AN:
1461698
Hom.:
4273
Cov.:
33
AF XY:
0.0623
AC XY:
45281
AN XY:
727168
show subpopulations
African (AFR)
AF:
0.319
AC:
10687
AN:
33468
American (AMR)
AF:
0.0396
AC:
1769
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.0237
AC:
620
AN:
26136
East Asian (EAS)
AF:
0.00207
AC:
82
AN:
39694
South Asian (SAS)
AF:
0.0986
AC:
8505
AN:
86254
European-Finnish (FIN)
AF:
0.0460
AC:
2458
AN:
53420
Middle Eastern (MID)
AF:
0.0518
AC:
299
AN:
5768
European-Non Finnish (NFE)
AF:
0.0557
AC:
61876
AN:
1111848
Other (OTH)
AF:
0.0695
AC:
4197
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.464
Heterozygous variant carriers
0
4585
9169
13754
18338
22923
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2466
4932
7398
9864
12330
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.124
AC:
18830
AN:
151952
Hom.:
2161
Cov.:
32
AF XY:
0.122
AC XY:
9061
AN XY:
74286
show subpopulations
African (AFR)
AF:
0.307
AC:
12719
AN:
41384
American (AMR)
AF:
0.0689
AC:
1052
AN:
15264
Ashkenazi Jewish (ASJ)
AF:
0.0248
AC:
86
AN:
3470
East Asian (EAS)
AF:
0.00425
AC:
22
AN:
5172
South Asian (SAS)
AF:
0.0997
AC:
480
AN:
4816
European-Finnish (FIN)
AF:
0.0494
AC:
521
AN:
10556
Middle Eastern (MID)
AF:
0.0476
AC:
14
AN:
294
European-Non Finnish (NFE)
AF:
0.0538
AC:
3655
AN:
67976
Other (OTH)
AF:
0.0944
AC:
199
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
751
1503
2254
3006
3757
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
192
384
576
768
960
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0424
Hom.:
88
Bravo
AF:
0.133
Asia WGS
AF:
0.0710
AC:
247
AN:
3478
EpiCase
AF:
0.0539
EpiControl
AF:
0.0538

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not specified Benign:2
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed.

PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Donnai-Barrow syndrome Benign:2
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.73
CADD
Benign
5.6
DANN
Benign
0.67
PhyloP100
0.29
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs13397109; hg19: chr2-170062078; API